Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P21817 (
RyR1
)
1,154
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Muscle growth is a complex phenomenon regulated by many factors, whereby net growth results from the combined action of synthesis and turnover. In pigs, two quantitative trait nucleotides (QTN) are known to have an important influence on muscle growth and fat deposition: one QTN is located in the
ryanodine receptor 1
(
RYR1
) gene (
RYR1
g.1843C>T) and the other, a paternally expressed QTN, is in the
insulin-like growth factor 2
(
IGF2
) gene (
IGF2
intron3-g.3072G>A). The mutation in
IGF2
abrogates in vitro interaction with a repressor, which leads to a threefold increase of
IGF2
expression in post-natal muscle. The family of the calpains, a family of Ca(2+)-sensitive muscle endopeptidases, and their specific inhibitor calpastatin play an important role in post-natal protein degradation, also influencing muscle and carcass traits. This study investigated the possible interactions between the genotypes of the
RYR1
and
IGF2
QTN on
IGF2
expression. Samples were taken from several muscles and from pigs at several ages, and messenger RNA expression levels were measured using a real-time quantification assay.
IGF2
expression in m. longissimus dorsi of animals with mutations in both
IGF2
and
RYR1
was significantly lower than in animals that inherited the
IGF2
mutation but were homozygous wildtype for
RYR1
.
...
PMID:The RYR1 g.1843C>T mutation is associated with the effect of the IGF2 intron3-g.3072G>A mutation on muscle hypertrophy. 1725 91